Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

PHASE3CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

February 7, 2006

Primary Completion Date

July 1, 2006

Study Completion Date

July 4, 2006

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

FF

fluticasone furoate 110 μg nasal spray

DRUG

Placebo

placebo nasal spray

Trial Locations (42)

1001

GSK Investigational Site, Grafton

1311

GSK Investigational Site, Auckland

1701

GSK Investigational Site, Auckland

2050

GSK Investigational Site, Camperdown

3004

GSK Investigational Site, Melbourne

3052

GSK Investigational Site, Parkville

3169

GSK Investigational Site, Clayton

4021

GSK Investigational Site, Kippa-Ring

5065

GSK Investigational Site, Toorak Gardens

6009

GSK Investigational Site, Nedlands

13125

GSK Investigational Site, Berlin

13419

GSK Investigational Site, Tallinn

14057

GSK Investigational Site, Berlin

19055

GSK Investigational Site, Schwerin

20249

GSK Investigational Site, Hamburg

20902

GSK Investigational Site, Wheaton

21236

GSK Investigational Site, Baltimore

44718

GSK Investigational Site, Canton

51014

GSK Investigational Site, Tartu

55402

GSK Investigational Site, Minneapolis

92123

GSK Investigational Site, San Diego

123095

GSK Investigational Site, Moscow

129010

GSK Investigational Site, Moscow

190013

GSK Investigational Site, Saint Petersburg

02747

GSK Investigational Site, North Dartmouth

02906

GSK Investigational Site, Providence

05403

GSK Investigational Site, South Burlington

L5A 1N1

GSK Investigational Site, Mississauga

K1Y 4G2

GSK Investigational Site, Ottawa

M9W 4L6

GSK Investigational Site, Toronto

G8T 7A1

GSK Investigational Site, Trois-Rivières

LV 3701

GSK Investigational Site, Dobele

LV3401

GSK Investigational Site, Liepāja

LV1001

GSK Investigational Site, Riga

LV1021

GSK Investigational Site, Riga

LV 3100

GSK Investigational Site, Tukums

LT-50009

GSK Investigational Site, Kaunas

LT-76231

GSK Investigational Site, Šiauliai

LT-01117

GSK Investigational Site, Vilnius

LT-08661

GSK Investigational Site, Vilnius

LT-09311

GSK Investigational Site, Vilnius

123 182

GSK Investigational Site, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY